Identification of an altered splice site in Ashkenazi Tay-Sachs disease

Nature. 1988 May 5;333(6168):85-6. doi: 10.1038/333085a0.

Abstract

Tay-Sachs disease is an autosomal recessive genetic disorder resulting from mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme, beta-N-acetylhexosaminidase A (ref. 1). A relatively high frequency of carriers (1/27) of a lethal, infantile form of the disease is found in the Ashkenazi Jewish population, but it is not yet evident whether this has resulted from a founder effect and random genetic drift or from a selective advantage of heterozygotes. We have identified a single-base mutation in a cloned fragment of the HEXA gene from an Ashkenazi Jewish patient. This change, the substitution of a C for G in the first nucleotide of intron 12 is expected to result in defective splicing of the messenger RNA. A test for the mutant allele based on amplification of DNA by the 'polymerase chain rection and cleavage of a DdeI restriction site generated by the mutation revealed that this case and two other cases of the Ashkenazi, infantile form of Tay-Sachs disease are heterozygous for two different mutations. The occurrence of multiple mutant alleles warrants further examination of the selective advantage hypothesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cell Line
  • Cloning, Molecular
  • DNA / genetics*
  • Female
  • Gene Amplification
  • Humans
  • Male
  • Mutation
  • Pedigree
  • RNA Splicing*
  • RNA, Messenger / genetics*
  • Tay-Sachs Disease / genetics*

Substances

  • RNA, Messenger
  • DNA